Yuan-Min Zhou

Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion

Minke He, QiJiong Li, Ruhai Zou et al. · JAMA Oncology · 2019 · 548 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma

Minke He, Run-Bin Liang, Yang Zhao et al. · Therapeutic Advances in Medical Oncology · 2021 · 214 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular Carcinoma

Yu-Jie Xu, ZhiCheng Lai, Minke He et al. · Technology in Cancer Research & Treatment · 2021 · 34 citations · Full text

Medicine, Oncology, Pharmacology +16

Bis-Acridines as Lead Antiparasitic Agents: Structure-Activity Analysis of a Discrete Compound Library In Vitro

Conor R. Caffrey, Dietmar Steverding, Ryan Swenerton et al. · Antimicrobial Agents and Chemotherapy · 2007 · 31 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab with or Without Transhepatic Arterial Embolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and High Tumor Burden: A Multicenter Retrospective Study

Song Chen, Feng Shi, Zhiqiang Wu et al. · Journal of Hepatocellular Carcinoma · 2023 · 23 citations · Full text

Medicine, Oncology, Pharmacotherapy +16